Behavioral animal models to assess pro-cognitive treatments for schizophrenia

Handbook of Experimental Pharmacology

Volumn 213, Issue , 2012, Pages 39-79

  Young, Jared W ^a   Amitai, Nurith ^b   Geyer, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Animal models; Attention; CNTRICS; Cognition; Cognitive remediation; MATRICS; Mice; Rats; Schizophrenia; Validity

Indexed keywords

2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; ATOMOXETINE; BROMOCRIPTINE; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; PHYSOSTIGMINE; TACRINE; VOLINANSERIN;

ALERTNESS; ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ARTICLE; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; COGNITIVE DEFECT; COGNITIVE REMEDIATION; COGNITIVE THERAPY; CONSTRUCT VALIDITY; DRUG EFFICACY; EXECUTIVE FUNCTION; HUMAN; LEARNING; LONG TERM MEMORY; MAZE TEST; MEMORY; MEMORY DISORDER; NONHUMAN; OLFACTORY DISCRIMINATION; PATTERN RECOGNITION; PRIORITY JOURNAL; PROBLEM SOLVING; PROTEIN EXPRESSION; RECOGNITION MEMORY; RELATIONAL MEMORY; RESPONSE TIME; SCHIZOPHRENIA; SELECTIVE ATTENTION; SHORT TERM MEMORY; STIMULUS RESPONSE; TASK PERFORMANCE; WISCONSIN CARD SORTING TEST; WORKING MEMORY; ANIMAL; ATTENTION; DISEASE MODEL; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; REACTION TIME; REVIEW;

ANIMALS; ATTENTION; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; LEARNING; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; PROBLEM SOLVING; REACTION TIME; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84868334463     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-642-25758-2_3     Document Type: Article

References (250)

1. Abdul-Monim Z, Reynolds GP, Neill JC (2003) The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat. J Psychopharmacol 17:57-65 (Pubitemid 36373141)
2. Abdul-Monim Z, Reynolds GP, Neill JC (2006) The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm. Behav Brain Res 169:263-273
3. Abraham NM, Spors H, Carleton A, Margrie TW, Kuner T, Schaefer AT (2004) Maintaining accuracy at the expense of speed: stimulus similarity defines odor discrimination time in mice. Neuron 44:865-876 (Pubitemid 39575638)
4. Addy NA, Nakijama A, Levin ED (2003) Nicotinic mechanisms of memory: effects of acute local DHbetaE and MLA infusions in the basolateral amygdala. Brain Res Cogn Brain Res 16:51-57 (Pubitemid 36183540)
5. Amitai N, Markou A (2009) Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration. Psychopharmacology (Berl) 202:275-286
6. Amitai N, Semenova S, Markou A (2007) Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats. Psychopharma-cology (Berl) 193:521-537 (Pubitemid 47094377)
7. Ammassari-Teule M, Save E, de Marsanich B, Thinus-Blanc C (1998) Posterior parietal cortex lesions severely disrupt spatial learning in DBA mice characterized by a genetic hippocampal dysfunction. Behav Brain Res 95:85-90 (Pubitemid 28400374)
8. Antonova E, Parslow D, Brammer M, Simmons A, Williams S, Dawson GR, Morris RG (2010) Scopolamine disrupts hippocampal activity during allocentric spatial memory in humans: an fMRI study using a virtual reality analogue of the Morris Water Maze. J Psychopharmacol 25(9):1256-65
9. Arnsten AF (2004) Adrenergic targets for the treatment of cognitive deficits in schizophrenia. Psychopharmacology (Berl) 174:25-31 (Pubitemid 38925087)
10. Aron AR, Poldrack RA (2005) The cognitive neuroscience of response inhibition: relevance for genetic research in attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1285-1292 (Pubitemid 40798547)
11. Baddeley A (2001) The concept of episodic memory. Philos Trans R Soc Lond B Biol Sci 356:1345-1350 (Pubitemid 32956220)
12. Baddeley AD (1986) Working memory. Oxford University Press, Oxford
13. Balducci C, Nurra M, Pietropoli A, Samanin R, Carli M (2003) Reversal of visual attention dysfunction after AMPA lesions of the nucleus basalis magnocellularis (NBM) by the cholin-esterase inhibitor donepezil and by a 5-HT1A receptor antagonist WAY 100635. Psychophar-macology (Berl) 167:28-36 (Pubitemid 36535289)
14. Bancroft A, Levin ED (2000) Ventral hippocampal alpha4beta2 nicotinic receptors and chronic nicotine effects on memory. Neuropharmacology 39:2770-2778
15. Barch DM, Carter CS, Arnsten A, Buchanan RW, Cohen JD, Geyer M, Green MF, Krystal JH, Nuechterlein K, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T, Heinssen R (2009) Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting. Schizophr Bull 35:109-114
16. Barense MD, Fox MT, Baxter MG (2002) Aged rats are impaired on an attentional set-shifting task sensitive to medial frontal cortex damage in young rats. Learn Mem 9:191-201 (Pubitemid 36240691)
17. Barnes SA, Young JW, Neill JC (2011a) D(1) receptor activation improves vigilance in rats as measured by the 5-choice continuous performance test. Psychopharmacology (Berl) 220(1):129-41
18. Barnes SA, Young JW, Neill JC (2011b) Rats tested after a washout period from sub-chronic PCP administration exhibited impaired performance in the 5-Choice Continuous Performance Test (5C-CPT) when the attentional load was increased. Neuropharmacology 62(3):1432-41
19. Barnett JH, Robbins TW, Leeson VC, Sahakian BJ, Joyce EM, Blackwell AD (2010) Assessing cognitive function in clinical trials of schizophrenia. Neurosci Biobehav Rev 34:1161-1177
20. Benice TS, Raber J (2009) Dihydrotestosterone modulates spatial working-memory performance in male mice. J Neurochem 110:902-911
21. Berg EA (1948) A simple objective technique for measuring flexibility in thinking. J Gen Psychol 39:15-22
22. Bettany JH, Levin ED (2001) Ventral hippocampal alpha 7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial-arm maze. Pharmacol Biochem Behav 70:467-474 (Pubitemid 34131641)
23. Birrell JM, Brown VJ (2000) Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 20:4320-4324 (Pubitemid 30365702)
24. Bissonette GB, Martins GJ, Franz TM, Harper ES, Schoenbaum G, Powell EM (2008) Double dissociation of the effects of medial and orbital prefrontal cortical lesions on attentional and affective shifts in mice. J Neurosci 28:11124-11130
25. Blokland A (1998) Reaction time responding in rats. Neurosci Biobehav Rev 22:847-864 (Pubitemid 28493452)
26. Bodyak N, Slotnick B (1999) Performance of mice in an automated olfactometer: odor detection, discrimination and odor memory. Chem Senses 24:637-645
27. Bor D, Duncan J, Owen AM (2001) The role of spatial configuration in tests of working memory explored with functional neuroimaging. Scand J Psychol 42:217-224 (Pubitemid 33668474)
28. Bor D, Owen AM (2006) Working memory: linking capacity with selectivity. Curr Biol 16: R136-R138 (Pubitemid 43259342)
29. Bozikas VP, Kosmidis MH, Kiosseoglou G, Karavatos A (2006) Neuropsychological profile of cognitively impaired patients with schizophrenia. Compr Psychiatry 47:136-143 (Pubitemid 43259419)
30. Brigman JL, Bussey TJ, Saksida LM, Rothblat LA (2005) Discrimination of multidimensional visual stimuli by mice: intra- and extradimensional shifts. Behav Neurosci 119:839-842 (Pubitemid 40934376)
31. Bromley-Brits K, Deng Y, Song W (2011) Morris water maze test for learning and memory deficits in Alzheimer's disease model mice. J Vis Exp 53. pii: 2920. doi: 10.3791/2920
32. Buchanan RW, Conley RR, Dickinson D, Ball MP, Feldman S, Gold JM, McMahon RP (2007a) Galantamine for the Treatment of Cognitive Impairments in People With Schizophrenia. Am J Psychiatry 165(1):82-9
33. Buchanan RW, Davis M, Goff D, Green MF, Keefe RS, Leon AC, Nuechterlein KH, Laughren T, Levin R, Stover E, Fenton W, Marder SR (2005) A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull 31:5-19 (Pubitemid 41214353)
34. Buchanan RW, Freedman R, Javitt DC, Abi-Dargham A, Lieberman JA (2007b) Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia. Schizophr Bull 33:1120-1130 (Pubitemid 47347922)
35. Burk JA (2004) Introduction of a retention interval in a sustained attention task in rats: effects of a visual distracter and increasing the inter-trial interval. Behav Processes 67:521-531 (Pubitemid 39420158)
36. Bushnell PJ (1998) Behavioral approaches to the assessment of attention in animals. Psychophar-macology (Berl) 138:231-259 (Pubitemid 28365488)
37. Bushnell PJ, Kelly KL, Crofton KM (1994) Effects of toluene inhalation on detection of auditory signals in rats. Neurotoxicol Teratol 16:149-160 (Pubitemid 24128566)
38. Bushnell PJ, Oshiro WM, Padnos BK (1997) Detection of visual signals by rats: effects of chlordiazepoxide and cholinergic and adrenergic drugs on sustained attention. Psychopharma-cology (Berl) 134:230-241 (Pubitemid 27520977)
39. Bussey TJ, Holmes A, Lyon L, Mar AC, McAllister KA, Nithianantharajah J, Oomen CA, Saksida LM (2011) New translational assays for preclinical modelling of cognition in schizophrenia: The touchscreen testing method for mice and rats. Neuropharmacology 62 (3):1191-203
40. Caine SB, Negus SS, Mello NK (1999) Method for training operant responding and evaluating cocaine self-administration behavior in mutant mice. Psychopharmacology (Berl) 147:22-24 (Pubitemid 30010016)
41. Calcagno E, Carli M, Baviera M, Invernizzi RW (2009) Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade. J Neurochem 108:521-532
42. Carli M, Baviera M, Invernizzi RW, Balducci C (2006) Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats. Neuropsychopharmacology 31:757-767
43. Carli M, Robbins TW, Evenden JL, Everitt BJ (1983) Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9:361-380 (Pubitemid 13002330)
44. Carrozzo M, Koch G, Turriziani P, Caltagirone C, Carlesimo GA, Lacquaniti F (2005) Integration of cognitive allocentric information in visuospatial short-term memory through the hippocampus. Hippocampus 15:1072-1084 (Pubitemid 43056995)
45. Carter CS, Barch DM (2007) Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative. Schizophr Bull 33:1131-1137 (Pubitemid 47347921)
46. Cassens G, Inglis AK, Appelbaum PS, Gutheil TG (1990) Neuroleptics: effects on neuropsycho-logical function in chronic schizophrenic patients. Schizophr Bull 16:477-499
47. Cave CB, Squire LR (1992) Intact verbal and nonverbal short-term memory following damage to the human hippocampus. Hippocampus 2:151-163
48. Chen WJ, Faraone SV (2000) Sustained attention deficits as markers of genetic susceptibility to schizophrenia. Am J Med Genet 97:52-57 (Pubitemid 30257326)
49. Chouinard S, Sepehry AA, Stip E (2007) Oral cholinesterase inhibitor add-on therapy for cognitive enhancement in schizophrenia: a quantitative systematic review, Part I. Clin Neuropharmacol 30:169-182 (Pubitemid 46871866)
50. Chudasama Y, Passetti F, Rhodes SE, Lopian D, Desai A, Robbins TW (2003) Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity. Behav Brain Res 146(1-2):105-119 (Pubitemid 37476138)
51. Chudasama Y, Robbins TW (2004) Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia. Psychopharmacology (Berl) 174:86-98 (Pubitemid 38925094)
52. Chuhan YS, Taukulis HK (2006) Impairment of single-trial memory formation by oral methyl-phenidate in the rat. Neurobiol Learn Mem 85:125-131 (Pubitemid 43247838)
53. Cornblatt B, Obuchowski M, Schnur D, O'Brien JD (1998) Hillside study of risk and early detection in schizophrenia. Br J Psychiatry Suppl 172:26-32 (Pubitemid 28258895)
54. Cornblatt B, Obuchowski M, Schnur DB, O'Brien JD (1997) Attention and clinical symptoms in schizophrenia. Psychiatr Q 68:343-359 (Pubitemid 27468946)
55. Cornblatt BA, Keilp JG (1994) Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull 20:31-46 (Pubitemid 24071091)
56. Cornblatt BA, Malhotra AK (2001) Impaired attention as an endophenotype for molecular genetic studies of schizophrenia. Am J Med Genet 105:11-15 (Pubitemid 32105185)
57. Curtis CE (2006) Prefrontal and parietal contributions to spatial working memory. Neuroscience 139:173-180
58. D'Hooge R, De Deyn PP (2001) Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36:60-90 (Pubitemid 32763130)
59. Deller T, Sarter M (1998) Effects of repeated administration of amphetamine on behavioral vigilance: evidence for "sensitized" attentional impairments. Psychopharmacology (Berl) 137:410-414 (Pubitemid 28305377)
60. Demeter E, Sarter M, Lustig C (2008) Rats and humans paying attention: cross-species task development for translational research. Neuropsychology 22:787-799
61. Dere E, Zheng-Fischhofer Q, Viggiano D, Gironi Carnevale UA, Ruocco LA, Zlomuzica A, Schnichels M, Willecke K, Huston JP, Sadile AG (2008) Connexin31.1 deficiency in the mouse impairs object memory and modulates open-field exploration, acetylcholine esterase levels in the striatum, and cAMP response element-binding protein levels in the striatum and piriform cortex. Neuroscience 153:396-405
62. DeVito LM, Konigsberg R, Lykken C, Sauvage M, Young WS 3rd, Eichenbaum H (2009) Vasopressin 1b receptor knock-out impairs memory for temporal order. J Neurosci 29:2676-2683
63. DeVito LM, Lykken C, Kanter BR, Eichenbaum H (2010) Prefrontal cortex: role in acquisition of overlapping associations and transitive inference. Learn Mem 17:161-167
64. Didriksen M, Kreilgaard M, Arnt J (2006) Sertindole, in contrast to clozapine and olanzapine, does not disrupt water maze performance after acute or chronic treatment. Eur J Pharmacol 542:108-115 (Pubitemid 44066366)
65. Drew LJ, Stark KL, Fenelon K, Karayiorgou M, Macdermott AB, Gogos JA (2011) Evidence for altered hippocampal function in a mouse model of the human 22q11.2 microdeletion. Mol Cell Neurosci 47:293-305
66. Dudchenko PA (2004) An overview of the tasks used to test working memory in rodents. Neurosci Biobehav Rev 28:699-709 (Pubitemid 39535867)
67. Dudchenko PA, Wood ER, Eichenbaum H (2000) Neurotoxic hippocampal lesions have no effect on odor span and little effect on odor recognition memory but produce significant impairments on spatial span, recognition, and alternation. J Neurosci 20:2964-2977 (Pubitemid 30220322)
68. Dunnett SB (1985) Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats. Psychopharmacology (Berl) 87:357-363 (Pubitemid 16225687)
69. Eagle DM, Baunez C (2010) Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neurosci Biobehav Rev 34:50-72
70. Eagle DM, Baunez C, Hutcheson DM, Lehmann O, Shah AP, Robbins TW (2008) Stop-signal reaction-time task performance: role of prefrontal cortex and subthalamic nucleus. Cereb Cortex 18:178-188 (Pubitemid 350233064)
71. Eagle DM, Robbins TW (2003) Lesions of the medial prefrontal cortex or nucleus accumbens core do not impair inhibitory control in rats performing a stop-signal reaction time task. Behav Brain Res 146:131-144 (Pubitemid 37476140)
72. Eagle DM, Tufft MR, Goodchild HL, Robbins TW (2007) Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacology (Berl) 192:193-206 (Pubitemid 46669203)
73. Echevarria DJ, Brewer A, Burk JA, Brown SN, Manuzon H, Robinson JK (2005) Construct validity of an operant signal detection task for rats. Behav Brain Res 157:283-290 (Pubitemid 40082571)
74. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98:6917-6922 (Pubitemid 32538317)
75. Erlenmeyer-Kimling L (2000) Neurobehavioral deficits in offspring of schizophrenic parents: liability indicators and predictors of illness. Am J Med Genet 97:65-71 (Pubitemid 30257328)
76. Fagerlund B, Mackeprang T, Gade A, Glenthoj BY (2004) Effects of low-dose risperidone and low-dose zuclopenthixol on cognitive functions in first-episode drug-naive schizophrenic patients. CNS Spectr 9:364-374 (Pubitemid 38649725)
77. Fields RB, Van Kammen DP, Peters JL, Rosen J, Van Kammen WB, Nugent A, Stipetic M, Linnoila M (1988) Clonidine improves memory function in schizophrenia independently from change in psychosis. Preliminary findings. Schizophr Res 1:417-423 (Pubitemid 19039471)
78. Fletcher PJ, Tampakeras M, Sinyard J, Higgins GA (2007) Opposing effects of 5-HT(2A) and 5-HT(2 C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test. Psychopharmacology (Berl) 195:223-234 (Pubitemid 350045843)
79. Fletcher PJ, Tenn CC, Rizos Z, Lovic V, Kapur S (2005) Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex. Psychopharmacology (Berl) 183:190-200 (Pubitemid 41609271)
80. Floresco SB, Geyer MA, Gold LH, Grace AA (2005) Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia. Schizophr Bull 31:888-894 (Pubitemid 41437783)
81. Folley BS, Astur R, Jagannathan K, Calhoun VD, Pearlson GD (2010) Anomalous neural circuit function in schizophrenia during a virtual Morris water task. Neuroimage 49:3373-3384
82. Friedman HR, Goldman-Rakic PS (1988) Activation of the hippocampus and dentate gyrus by working-memory: a 2-deoxyglucose study of behaving rhesus monkeys. J Neurosci 8:4693-4706 (Pubitemid 19015152)
83. Friedman JI, Adler DN, Temporini HD, Kemether E, Harvey PD, White L, Parrella M, Davis KL (2001) Guanfacine treatment of cognitive impairment in schizophrenia. Neuropsychophar-macology 25:402-409 (Pubitemid 32777790)
84. Geyer MA (2010) New opportunities in the treatment of cognitive impairments associated with schizophrenia. Curr Direct Psychol Sci 19:264-269
85. Gibbs SE, D'Esposito M (2005) A functional MRI study of the effects of bromocriptine, a dopamine receptor agonist, on component processes of working memory. Psychopharmacology (Berl) 180:644-653 (Pubitemid 41317861)
86. Goetghebeur P, Dias R (2009) Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat-a back translational study. Psychopharmacology (Berl) 202:287-293
87. Gold JM, Hahn B, Zhang WW, Robinson BM, Kappenman ES, Beck VM, Luck SJ (2010) Reduced capacity but spared precision and maintenance of working memory representations in schizophrenia. Arch Gen Psychiatry 67:570-577
88. Goldberg TE, Weinberger DR (1995) Thought disorder, working memory and attention: interrelationships and the effects of neuroleptic medications. Int Clin Psychopharmacol 10(Suppl 3): 99-104 (Pubitemid 26054883)
89. Goldberg TE, Weinberger DR, Berman KF, Pliskin NH, Podd MH (1987) Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiatry 44:1008-1014 (Pubitemid 18009657)
90. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153:321-330 (Pubitemid 26074706)
91. Green MF (2006) Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry 67:e12
92. Green MF, Marder SR, Glynn SM, McGurk SR, Wirshing WC, Wirshing DA, Liberman RP, Mintz J (2002) The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone. Biol Psychiatry 51:972-978 (Pubitemid 34607714)
93. Grottick AJ, Haman M, Wyler R, Higgins GA (2003) Reversal of a vigilance decrement in the aged rat by subtype-selective nicotinic ligands. Neuropsychopharmacology 28:880-887
94. Grottick AJ, Higgins GA (2002) Assessing a vigilance decrement in aged rats: effects of prefeeding, task manipulation, and psychostimulants. Psychopharmacology (Berl) 164:33-41 (Pubitemid 35203840)
95. Grottick AJ, Trube G, Corrigall WA, Huwyler J, Malherbe P, Wyler R, Higgins GA (2000) Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. J Pharmacol Exp Ther 294:1112-1119 (Pubitemid 30666867)
96. Grottick AJ, Wyler R, Higgins GA (2001) A study of the nicotinic agonist SIB-1553A on locomotion and attention as measured by the five-choice serial reaction time task. Pharmacol Biochem Behav 70:505-513 (Pubitemid 34131645)
97. Hagan JJ, Jones DN (2005) Predicting drug efficacy for cognitive deficits in schizophrenia. Schizophr Bull 31:830-853 (Pubitemid 41437777)
98. Harvey PD, Green MF, McGurk SR, Meltzer HY (2003) Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study. Psycho-pharmacology (Berl) 169:404-411 (Pubitemid 37255530)
99. Harvey PD, Keefe RS (2001) Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am J Psychiatry 158:176-184 (Pubitemid 32116511)
100. Harvey PD, Meltzer H, Simpson GM, Potkin SG, Loebel A, Siu C, Romano SJ (2004) Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia. Schizophr Res 66:101-113 (Pubitemid 38041108)
101. Hashimoto K, Fujita Y, Iyo M (2007) Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors. Neuropsychopharmacology 32:514-521
102. Hatcher PD, Brown VJ, Tait DS, Bate S, Overend P, Hagan JJ, Jones DN (2005) 5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats. Psychopharmacology (Berl) 181:253-259 (Pubitemid 41492195)
103. Heinrichs RW (2007) Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry 64:631-632 (Pubitemid 46878664)
104. Hodges H, Green S (1986) Effects of chlordiazepoxide on cued radial maze performance in rats. Psychopharmacology (Berl) 88:460-466 (Pubitemid 16109555)
105. *) nAChRs: underlying cholinergic mechanisms. Neuropsychopharmacology 35:1391-1401
106. Hoyle E, Genn RF, Fernandes C, Stolerman IP (2006) Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task. Psychopharmacology (Berl) 189:211-223 (Pubitemid 44691543)
107. Huang YW, Hu WW, Chen Z, Zhang LS, Shen HQ, Timmerman H, Leurs R, Yanai K (2004) Effect of the histamine H3-antagonist clobenpropit on spatial memory deficits induced by MK-801 as evaluated by radial maze in Sprague-Dawley rats. Behav Brain Res 151:287-293 (Pubitemid 38501451)
108. Humby T, Laird FM, Davies W, Wilkinson LS (1999) Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype. Eur J Neurosci 11:2813-2823 (Pubitemid 29364198)
109. Idris N, Neill J, Grayson B, Bang-Andersen B, Witten LM, Brennum LT, Arnt J (2010) Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms. Psychopharmacology (Berl) 208:23-36
110. Idris NF, Repeto P, Neill JC, Large CH (2005) Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat. Psychopharmacology (Berl) 179:336-348
111. Jarrold C, Towse JN (2006) Individual differences in working memory. Neuroscience 139:39-50
112. Jazbec S, Pantelis C, Robbins T, Weickert T, Weinberger DR, Goldberg TE (2007) Intra-dimensional/extra-dimensional set-shifting performance in schizophrenia: impact of distractors. Schizophr Res 89:339-349 (Pubitemid 44881281)
113. Jeneson A, Mauldin KN, Squire LR (2010) Intact working memory for relational information after medial temporal lobe damage. J Neurosci 30:13624-13629
114. Jennings JW, Keefer LH (1969) Olfactory learning set in two varieties of domestic rat. Psychol Rep 24:3-15
115. Johannsen P (2004) Long-term cholinesterase inhibitor treatment of Alzheimer's disease. CNS Drugs 18:757-768 (Pubitemid 39410100)
116. Jones DN, Higgins GA (1995) Effect of scopolamine on visual attention in rats. Psychopharmacology (Berl) 120:142-149
117. Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, Murray RM, Markwick A, Lewis SW (2006) Randomized controlled trial of the effect on Quality of Life of secondvs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 63:1079-1087 (Pubitemid 44498387)
118. Kane MJ, Engle RW (2002) The role of prefrontal cortex in working-memory capacity, executive attention, and general fluid intelligence: an individual-differences perspective. Psychon Bull Rev 9:637-671
119. Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, Hsiao JK, Lieberman JA (2007) Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry 64:633-647 (Pubitemid 46878665)
120. Keefe RS, Seidman LJ, Christensen BK, Hamer RM, Sharma T, Sitskoorn MM, Rock SL, Woolson S, Tohen M, Tollefson GD, Sanger TM, Lieberman JA (2006) Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis. Biol Psychiatry 59:97-105 (Pubitemid 43117498)
121. Keefe RS, Silva SG, Perkins DO, Lieberman JA (1999) The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull 25:201-222 (Pubitemid 29272501)
122. Kern RS, Green MF, Marshall BD Jr, Wirshing WC, Wirshing D, McGurk S, Marder SR, Mintz J (1998) Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients. Biol Psychiatry 44:726-732 (Pubitemid 28496788)
123. Kern RS, Green MF, Marshall BD Jr, Wirshing WC, Wirshing D, McGurk SR, Marder SR, Mintz J (1999) Risperidone versus haloperidol on secondary memory: can newer medications aid learning? Schizophr Bull 25:223-232 (Pubitemid 29272502)
124. King MV, Sleight AJ, Woolley ML, Topham IA, Marsden CA, Fone KC (2004) 5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation - an effect sensitive to NMDA receptor antagonism. Neuropharmacology 47:195-204 (Pubitemid 38824643)
125. Kirkby DL, Jones DN, Barnes JC, Higgins GA (1996) Effects of anticholinesterase drugs tacrine and E2020, the 5-HT(3) antagonist ondansetron, and the H(3) antagonist thioperamide, in models of cognition and cholinergic function. Behav Pharmacol 7:513-525 (Pubitemid 27046781)
126. Kobayashi S, Kametani H, Ugawa Y, Osanai M (1988) Age difference of response strategy in radial maze performance of Fischer-344 rats. Physiol Behav 42:277-280 (Pubitemid 18083972)
127. Koelega HS (1993) Stimulant drugs and vigilance performance: a review. Psychopharmacology (Berl) 111:1-16 (Pubitemid 23101345)
128. Kohler CG, Martin EA, Kujawski E, Bilker W, Gur RE, Gur RC (2007) No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia. Cognit Neuropsychiatry 12:412-421 (Pubitemid 47254593)
129. Kraepelin E (1893) Ein kurzes Lahrbruch fur Studirende und Aerzte Leipzig Verlag von Ambr. Abel 4e Auflage, Heidelberg, pp 435-445
130. KunitachiS, FujitaY, IshimaT, KohnoM, HorioM, TanibuchiY, ShirayamaY, IyoM, Hashimoto K (2009) Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors. Brain Res 1279:189-196
131. Lapiz MD, Morilak DA (2006) Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 137:1039-1049 (Pubitemid 43053965)
132. Laurent A, Saoud M, Bougerol T, d'Amato T, Anchisi AM, Biloa-Tang M, Dalery J, Rochet T (1999) Attentional deficits in patients with schizophrenia and in their non-psychotic first-degree relatives. Psychiatry Res 89:147-59 (Pubitemid 30052998)
133. Lee J, Park S (2005) Working memory impairments in schizophrenia: a meta-analysis. J Abnorm Psychol 114:599-611 (Pubitemid 41746997)
134. Leeson VC, Robbins TW, Matheson E, Hutton SB, Ron MA, Barnes TR, Joyce EM (2009) Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatry 66:586-593
135. Leonard J (1959) Five-choice serial reaction apparatus. Medical Research Council Applied Psychology Reports, Cambridge
136. Levin ED (2002) Nicotinic receptor subtypes and cognitive function. J Neurobiol 53:633-640 (Pubitemid 35375592)
137. Levin ED, Bradley A, Addy N, Sigurani N (2002) Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory. Neuroscience 109:757-765 (Pubitemid 34260859)
138. Levin ED, Kim P, Meray R (1996) Chronic nicotine working and reference memory effects in the 16-arm radial maze: interactions with D1 agonist and antagonist drugs. Psychopharmacology (Berl) 127:25-30 (Pubitemid 26285679)
139. Levin ED, Simon BB (1998) Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl) 138:217-230 (Pubitemid 28365487)
140. Lewis SW, Barnes TR, Davies L, Murray RM, Dunn G, Hayhurst KP, Markwick A, Lloyd H, Jones PB (2006) Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull 32:715-723 (Pubitemid 44412859)
141. Lindner MD, Hogan JB, Hodges DB Jr, Orie AF, Chen P, Corsa JA, Leet JE, Gillman KW, Rose GM, Jones KM, Gribkoff VK (2006) Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping. Psychopharmacology (Berl) 188:629-640 (Pubitemid 46758973)
142. Logan GD, Cowan WB, Davis KA (1984) On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform 10:276-291
143. Lyon M (1991) Animal models of mania and schizophrenia. In: Willner P (ed) Behavioural models in psychopharmacology: Theoretical. Cambridge University, Cambridge, Industrial and clinical perspectives, pp 253-310
144. Marder SR, Fenton W (2004) Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr Res 72:5-9 (Pubitemid 39452900)
145. Markham MR, Butt AE, Dougher MJ (1996) A computer touch-screen apparatus for training visual discriminations in rats. J Exp Anal Behav 65:173-182 (Pubitemid 126420957)
146. Marston HM (1996) Analysis of cognitive function in animals, the value of SDT. Brain Res Cogn Brain Res 3:269-277 (Pubitemid 26198358)
147. Martin LF, Kem WR, Freedman R (2004) Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology (Berl) 174:54-64 (Pubitemid 38925091)
148. Martinez V, Sarter M (2008) Detection of the moderately beneficial cognitive effects of low-dose treatment with haloperidol or clozapine in an animal model of the attentional impairments of schizophrenia. Neuropsychopharmacology 33:2635-2647
149. Matthysse S (1986) Animal models in psychiatric research. Prog Brain Res 65:259-270 (Pubitemid 17150944)
150. Mathes B, Wood SJ, Proffitt TM, Stuart GW, Buchanan JA, Velakoulis D, Brewer WJ, McGorry PD, Pantelis C (2005) Early processing deficits in object working memory in first-episode schizophreniform psychosis and established schizophrenia. Psychol Med 35:1053-1062 (Pubitemid 41015703)
151. McGaughy J, Kaiser T, Sarter M (1996) Behavioral vigilance following infusions of 192 IgGsaporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. Behav Neurosci 110:247-265 (Pubitemid 26127571)
152. McGaughy J, Sarter M (1995) Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology (Berl) 117:340-357
153. McLean SL, Beck JP, Woolley ML, Neill JC (2008) A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats. Behav Brain Res 189:152-158
154. McLean SL, Grayson B, Harris M, Protheroe C, Bate S, Woolley ML, Neill JC (2010) Isolation rearing impairs novel object recognition and attentional set shifting performance in female rats. J Psychopharmacol 24:57-63
155. Mehta MA, Swainson R, Ogilvie AD, Sahakian J, Robbins TW (2001) Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers. Psychopharmacology (Berl) 159:10-20 (Pubitemid 34031245)
156. Meltzer HY, McGurk SR (1999) The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25:233-255 (Pubitemid 29272503)
157. Micheau J, Riedel G, Roloff EL, Inglis J, Morris RG (2004) Reversible hippocampal inactivation partially dissociates how and where to search in the water maze. Behav Neurosci 118:1022-1032 (Pubitemid 39346507)
158. Min SK, Moon IW, Ko RW, Shin HS (2001) Effects of transdermal nicotine on attention and memory in healthy elderly non-smokers. Psychopharmacology (Berl) 159:83-88
159. Mori K, Obara Y, Moriya T, Inatomi S, Nakahata N (2011) Effects of Hericium erinaceus on amyloid beta(25-35) peptide-induced learning and memory deficits in mice. Biomed Res 32:67-72
160. Morris RGM (1981) Spatial localization does not require the presence of local cues. Learning Motivation 12:239
161. Muir JL, Dunnett SB, Robbins TW, Everitt BJ (1992) Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task. Exp Brain Res 89:611-622
162. Muir JL, Everitt BJ, Robbins TW (1995) Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron. Psychopharmacology (Berl) 118:82-92
163. Muir JL, Everitt BJ, Robbins TW (1996) The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cereb Cortex 6:470-481
164. Muir JL, Fischer W, Bjorklund A (1999) Decline in visual attention and spatial memory in aged rats. Neurobiol Aging 20:605-615 (Pubitemid 30064406)
165. Muller U, von Cramon DY, Pollmann S (1998) D1-versus D2-receptor modulation of visuospatial working memory in humans. J Neurosci 18:2720-2728 (Pubitemid 28141817)
166. Murray GK, Cheng F, Clark L, Barnett JH, Blackwell AD, Fletcher PC, Robbins TW, Bullmore ET, Jones PB (2008) Reinforcement and reversal learning in first-episode psychosis. Schizophr Bull 34:848-855
167. Mutlu O, Ulak G, Celikyurt IK, Akar FY, Erden F (2011) Effects of olanzapine, sertindole and clozapine on learning and memory in the Morris water maze test in naive and MK-801-treated mice. Pharmacol Biochem Behav 98:398-404
168. Nagai T, Murai R, Matsui K, Kamei H, Noda Y, Furukawa H, Nabeshima T (2009) Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors. Psychopharmacology (Berl) 202:315-328
169. Navarra R, Graf R, Huang Y, Logue S, Comery T, Hughes Z, Day M (2008) Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Prog Neuropsychopharmacol Biol Psychiatry 32:34-41
170. Newhouse P, Singh A, Potter A (2004) Nicotine and nicotinic receptor involvement in neuropsy-chiatric disorders. Curr Top Med Chem 4:267-282 (Pubitemid 38842571)
171. Nieuwenstein MR, Aleman A, de Haan EH (2001) Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting Test. Continuous Performance Test. J Psychiatr Res 35:119-125 (Pubitemid 32506755)
172. Niimi K, Takahashi E, Itakura C (2008) Improved short-term memory and increased expression of NR2B observed in senescence-accelerated mouse (SAM) P6. Exp Gerontol 43:847-852
173. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK (2004) Identification of separable cognitive factors in schizophrenia. Schizophr Res 72:29-39 (Pubitemid 39452903)
174. Nuechterlein KH, Luck SJ, Lustig C, Sarter M (2009) CNTRICS final task selection: control of attention. Schizophr Bull 35:182-196
175. Olton DS, Samuelson RJ (1976) Remembrance of places passed: Spatial memory in rats. J Exp Psychol Anim Behav Proc 2:97-116
176. Olton DS, Werz MA (1978) Hippocampal function and behavior: spatial discrimination and response inhibition. Physiol Behav 20:597-605 (Pubitemid 8354389)
177. Owen AM, Roberts AC, Polkey CE, Sahakian BJ, Robbins TW (1991) Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 29:993-1006
178. Paine TA, Neve RL, Carlezon WA Jr (2009) Attention deficits and hyperactivity following inhibition of cAMP-dependent protein kinase within the medial prefrontal cortex of rats. Neuropsychopharmacology 34:2143-2155
179. Pantelis C, Barber FZ, Barnes TR, Nelson HE, Owen AM, Robbins TW (1999) Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophr Res 37:251-270 (Pubitemid 29298095)
180. Pantelis C, Barnes TR, Nelson HE, Tanner S, Weatherley L, Owen AM, Robbins TW (1997) Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain 120(Pt 10): 1823-1843 (Pubitemid 27443056)
181. Parasuraman R (1998) The attentive brain. MIT Press, MA, USA
182. Passetti F, Chudasama Y, Robbins TW (2002) The frontal cortex of the rat and visual attentional performance: dissociable functions of distinct medial prefrontal subregions. Cereb Cortex 12(12):1254-1268 (Pubitemid 35396963)
183. Pattij T, Janssen MC, Loos M, Smit AB, Schoffelmeer AN, van Gaalen MM (2007) Strain specificity and cholinergic modulation of visuospatial attention in three inbred mouse strains. Genes Brain Behav 6:579-587 (Pubitemid 47246223)
184. Pietrzak RH, Snyder PJ, Maruff P (2010) Amphetamine-related improvement in executive function in patients with chronic schizophrenia is modulated by practice effects. Schizophr Res 124:176-182
185. Prouteau A, Verdoux H, Briand C, Lesage A, Lalonde P, Nicole L, Reinharz D, Stip E (2004) The crucial role of sustained attention in community functioning in outpatients with schizophrenia. Psychiatry Res 129:171-177 (Pubitemid 39601813)
186. Purdon SE, Malla A, Labelle A, Lit W (2001) Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. J Psychiatry Neurosci 26:137-149 (Pubitemid 32373127)
187. Ragland JD, Cools R, Frank M, Pizzagalli DA, Preston A, Ranganath C, Wagner AD (2009) CNTRICS final task selection: long-term memory. Schizophr Bull 35:197-212
188. Rausch R, Babb TL (1993) Hippocampal neuron loss and memory scores before and after temporal lobe surgery for epilepsy. Arch Neurol 50:812-817 (Pubitemid 23229306)
189. Reeves SJ, Grasby PM, Howard RJ, Bantick RA, Asselin MC, Mehta MA (2005) A positron emission tomography (PET) investigation of the role of striatal dopamine (D2) receptor availability in spatial cognition. Neuroimage 28:216-226 (Pubitemid 41393901)
190. Rezvani AH, Caldwell DP, Levin ED (2005) Nicotinic-serotonergic drug interactions and attentional performance in rats. Psychopharmacology (Berl) 179:521-528 (Pubitemid 40674752)
191. Rezvani AH, Levin ED (2001) Cognitive effects of nicotine. Biol Psychiatry 49:258-267 (Pubitemid 32178435)
192. Rezvani AH, Levin ED (2003) Nicotinic-glutamatergic interactions and attentional performance on an operant visual signal detection task in female rats. Eur J Pharmacol 465:83-90 (Pubitemid 36332279)
193. Riccio CA, Reynolds CR, Lowe P, Moore JJ (2002) The continuous performance test: a window on the neural substrates for attention? Arch Clin Neuropsychol 17:235-272 (Pubitemid 34201745)
194. Richelson E, Souder T (2000) Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci 68:29-39
195. Rinberg D, Koulakov A, Gelperin A (2006) Speed-accuracy tradeoff in olfaction. Neuron 51:351-358 (Pubitemid 44118715)
196. Ritsner MS, Blumenkrantz H (2007) Predicting domain-specific insight of schizophrenia patients from symptomatology, multiple neurocognitive functions, and personality related traits. Psychiatry Res 149:59-69 (Pubitemid 46108091)
197. Robbins TW (1998) Arousal and attention: psychopharmacological and neuropsychophysical studies in experimental animals. In: Parasuraman R (ed) The attentive brain. MIT Press, Cambridge
198. Robbins TW (2002) The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163:362-380
199. Robinson ES, Eagle DM, Mar AC, Bari A, Banerjee G, Jiang X, Dalley JW, Robbins TW (2008) Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 33:1028-1037 (Pubitemid 351367544)
200. Rollnik JD, Borsutzky M, Huber TJ, Mogk H, Seifert J, Emrich HM, Schneider U (2002) Shortterm cognitive improvement in schizophrenics treated with typical and atypical neuroleptics. Neuropsychobiology 45:74-80 (Pubitemid 34224981)
201. Rosvold H, Sarason AM, Bransome ADJ, Beck LH (1956) A continuous performance test of brain damage. J Consult Psychol 20:343-350
202. Roth BL, Hanizavareh SM, Blum AE (2004) Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders. Psycho-pharmacology (Berl) 174:17-24 (Pubitemid 38925086)
203. Rushforth SL, Allison C, Wonnacott S, Shoaib M (2010) Subtype-selective nicotinic agonists enhance olfactory working memory in normal rats: a novel use of the odour span task. Neurosci Lett 471:114-118
204. Rusted JM, Warburton DM (1992) Facilitation of memory by post-trial administration of nicotine: evidence for an attentional explanation. Psychopharmacology (Berl) 108:452-455
205. Salgado-Pineda P, Baeza I, Perez-Gomez M, Vendrell P, Junque C, Bargallo N, Bernardo M (2003) Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. Neuroimage 19:365-375 (Pubitemid 39665687)
206. Sarter M, Martinez V, Kozak R (2009) A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia. Psychopharmacology (Berl) 202:237-258
207. Sarter M, McGaughy J (1998) Assessment of sustained and divided attention in rats: aspects of validity; comment. Psychopharmacology (Berl) 138:260-2, discussion 263-5 (Pubitemid 28365489)
208. Sass KJ, Spencer DD, Kim JH, Westerveld M, Novelly RA, Lencz T (1990) Verbal memory impairment correlates with hippocampal pyramidal cell density. Neurology 40:1694-1697 (Pubitemid 20383134)
209. Sharma T, Mockler D (1998) The cognitive efficacy of atypical antipsychotics in schizophrenia. J Clin Psychopharmacol 18:12S-19S (Pubitemid 28191581)
210. Sharma T, Reed C, Aasen I, Kumari V (2006) Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation. Schizophr Res 85:73-83 (Pubitemid 43947524)
211. Silvers JM, Harrod SB, Mactutus CF, Booze RM (2007) Automation of the novel object recognition task for use in adolescent rats. J Neurosci Methods 166:99-103 (Pubitemid 47374810)
212. Slotnick B (2001) Animal cognition and the rat olfactory system. Trends Cogn Sci 5:216-222 (Pubitemid 32372628)
213. Slotnick BM, Risser JM (1990) Odor memory and odor learning in rats with lesions of the lateral olfactory tract and mediodorsal thalamic nucleus. Brain Res 529:23-29 (Pubitemid 20326836)
214. Smith RC, Warner-Cohen J, Matute M, Butler E, Kelly E, Vaidhyanathaswamy S, Khan A (2006) Effects of nicotine nasal spray on cognitive function in schizophrenia. Neuropsychophar-macology 31:637-643 (Pubitemid 43276979)
215. Steckler T, Muir JL (1996) Measurement of cognitive function: relating rodent performance with human minds. Brain Res Cogn Brain Res 3:299-308 (Pubitemid 26198361)
216. Stip E, Sepehry AA, Chouinard S (2007) Add-on therapy with acetylcholinesterase inhibitors for memory dysfunction in schizophrenia: a systematic quantitative review, part 2. Clin Neuropharmacol 30:218-229 (Pubitemid 47356719)
217. Swerdlow NR (2011) Are we studying and treating schizophrenia correctly? Schizophr Res 130:1-10
218. Tarantino IS, Sharp RF, Geyer MA, Meves JM, Young JW (2011) Working memory span capacity improved by a D2 but not D1 receptor family agonist. Behav Brain Res 219:181-188
219. Thomsen MS, Christensen DZ, Hansen HH, Redrobe JP, Mikkelsen JD (2009) Alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment. Neuropharmacology 56:1001-1009
220. Titone D, Ditman T, Holzman PS, Eichenbaum H, Levy DL (2004) Transitive inference in schizophrenia: impairments in relational memory organization. Schizophr Res 68:235-247 (Pubitemid 38526146)
221. Tunbridge EM, Bannerman DM, Sharp T, Harrison PJ (2004) Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci 24:5331-5335 (Pubitemid 38747674)
222. Turchi J, Holley LA, Sarter M (1995) Effects of nicotinic acetylcholine receptor ligands on behavioral vigilance in rats. Psychopharmacology (Berl) 118:195-205
223. Turchi J, Sarter M (2000) Cortical cholinergic inputs mediate processing capacity: effects of 192 IgG-saporin-induced lesions on olfactory span performance. Eur J Neurosci 12:4505-4514 (Pubitemid 32037858)
224. Turner DC, Clark L, Dowson J, Robbins TW, Sahakian BJ (2004a) Modafinil improves cognition and response inhibition in adult attention-deficit/ hyperactivity disorder. Biol Psychiatry 55:1031-1040 (Pubitemid 38581919)
225. Turner DC, Clark L, Pomarol-Clotet E, McKenna P, Robbins TW, Sahakian BJ (2004b) Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology 29:1363-1373 (Pubitemid 38780659)
226. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ (2003) Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) 165:260-269 (Pubitemid 36197601)
227. Twamley EW, Burton CZ, Vella L (2011) Compensatory cognitive training for psychosis: who benefits? Who stays in treatment? Schizophr Bull 37(Suppl 2):S55-S62
228. Uchida N, Mainen ZF (2003) Speed and accuracy of olfactory discrimination in the rat. Nat Neurosci 6:1224-1229 (Pubitemid 37346044)
229. Velligan DI, Newcomer J, Pultz J, Csernansky J, Hoff AL, Mahurin R, Miller AL (2002) Does cognitive function improve with quetiapine in comparison to haloperidol? Schizophr Res 53:239-248 (Pubitemid 34008588)
230. Velligan DI, Prihoda TJ, Sui D, Ritch JL, Maples N, Miller AL (2003) The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings. J Clin Psychiatry 64:524-531 (Pubitemid 36618280)
231. Wang D, Noda Y, Zhou Y, Nitta A, Furukawa H, Nabeshima T (2007) Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model. Neuropharmacology 52:1179-1187
232. Warburton DM, Rusted JM, Fowler J (1992) A comparison of the attentional and consolidation hypotheses for the facilitation of memory by nicotine. Psychopharmacology (Berl) 108:443-447
233. Wenk GL (2004) Assessment of spatial memory using the radial arm maze and Morris water maze. Curr Protoc Neurosci Chapter 8: Unit 8 5A
234. Wesnes K, Warburton DM (1984) Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology (Berl) 82:147-150 (Pubitemid 14184530)
235. Widholm JJ, Clarkson GB, Strupp BJ, Crofton KM, Seegal RF, Schantz SL (2001) Spatial reversal learning in Aroclor 1254-exposed rats: sex-specific deficits in associative ability and inhibitory control. Toxicol Appl Pharmacol 174:188-198 (Pubitemid 32675521)
236. Widholm JJ, Seo BW, Strupp BJ, Seegal RF, Schantz SL (2003) Effects of perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on spatial and visual reversal learning in rats. Neurotoxicol Teratol 25:459-471 (Pubitemid 36694462)
237. Wietrzych M, Meziane H, Sutter A, Ghyselinck N, Chapman PF, Chambon P, Krezel W (2005) Working memory deficits in retinoid X receptor gamma-deficient mice. Learn Mem 12:318-326 (Pubitemid 40958343)
238. Yamada M, Hayashida M, Zhao Q, Shibahara N, Tanaka K, Miyata T, Matsumoto K (2011) Ameliorative effects of yokukansan on learning and memory deficits in olfactory bulbectomized mice. J Ethnopharmacol 135(3):737-46
239. Young JW, Crawford N, Kelly JS, Kerr LE, Marston HM, Spratt C, Finlayson K, Sharkey J (2007a) Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. Eur Neuropsychopharmacol 17:145-155 (Pubitemid 44802833)
240. Young JW, Finlayson K, Spratt C, Marston HM, Crawford N, Kelly JS, Sharkey J (2004) Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor. Neuropsychopharmacology 29:891-900 (Pubitemid 38526789)
241. Young JW, Geyer MA (2010) Action of modafinil-increased motivation via the dopamine transporter inhibition and D1 receptors? Biol Psychiatry 67:784-787
242. Young JW, Geyer MA, subcommittee p (2007b) Report on putative preclinical models of the MATRICS battery. http://www.turns.ucla.edu/preclinical-TURNS- report-2006b.pdf
243. Young JW, Henry BL, Geyer MA (2011a) Predictive animal models of mania: hits, misses and future directions. Br J Pharmacol 164:1263-1284
244. Young JW, Kerr LE, Kelly JS, Marston HM, Spratt C, Finlayson K, Sharkey J (2007c) The odour span task: a novel paradigm for assessing working memory in mice. Neuropharmacology 52:634-645 (Pubitemid 46137979)
245. Young JW, Light GA, Marston HM, Sharp R, Geyer MA (2009a) The 5-choice continuous performance test: evidence for a translational test of vigilance for mice. PLoS One 4:e4227
246. Young JW, Meves JM, Tarantino IS, Caldwell S, Geyer MA (2011b) Delayed procedural learning in alpha7-nicotinic acetylcholine receptor knockout mice. Genes Brain Behav 10:720-733
247. Young JW, Powell SB, Geyer MA (2011c) Mouse pharmacological models of cognitive disruption relevant to schizophrenia. Neuropharmacology 62(3):1381-90
248. Young JW, Powell SB, Risbrough V, Marston HM, Geyer MA (2009b) Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther 122:150-202
249. Young JW, Powell SB, Scott CN, Zhou X, Geyer MA (2011d) The effect of reduced dopamine D4 receptor expression in the 5-choice continuous performance task: Separating response inhibition from premature responding. Behav Brain Res 222:183-192
250. Young JW, Sharkey J, Finlayson K (2009c) Progressive impairment in olfactory working memory in a mouse model of mild cognitive impairment. Neurobiol Aging 30:1430-1443